SoftBank disclosed a 20.45M share position in PacBio (PACB) and 14.67M share position in Recursion Pharmaceuticals (RXRX) in a regulatory ...
1) The IPO and sell-down of the core Japanese telecom business. SoftBank sold around 36% of its shares of the core domestic telecom business in 2018 in an IPO, with the proceeds being used for ...
Japan's SoftBank Group booked a surprise $2.4 billion quarterly loss on Wednesday, hit by a decline in the value of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results